Skip to main content

Table 1 The Characteristics of patients with Kawasaki disease according to IVIG responsiveness

From: A decision tree model for predicting intravenous immunoglobulin resistance and coronary artery involvement in Kawasaki disease

  IVIG responders (N = 117) IVIG non-responders (N = 785) P value
Age, months 31.43 ± 22.44 36.39 ± 27.70 0.07
Sex
 Male, n (%) 444 (56.5%) 67 (60.3%) 0.47
 Female, n (%) 341 (43.4%) 44 (39.6%)  
WBC, 103/L 14.8 ± 4.6 15.2 ± 6.0 0.36
ANC, 103/L 9.56 ± 4.4 11.36 ± 5.3  < 0.01*
Hematocrit, % 34.3 ± 12.7 35.2 ± 5.7 0.43
Platelet, 103/L 361.46 ± 100.66 322.14 ± 105.44  < 0.01*
AST, U/L 79.8 ± 138.8 135.6 ± 201.5  < 0.01*
ALT, U/L 79.7 ± 127.9 159.1 ± 188.3  < 0.01*
Albumin, g/dL 3.97 ± 0.9 3.80 ± 0.5 0.06
Total bilirubin, mg/dL 0.62 ± 0.8 1.38 ± 1.4  < 0.01*
CRP, mg/dL 8.02 ± 5.9 9.92 ± 6.3  < 0.01*
Na, mmol/L 136.3 ± 2.8 135.8 ± 2.5 0.09
NT-proBNP, pg/mL 1231.9 ± 2136.5 2425.4 ± 4459.3  < 0.01*
Development of CADs, n (%) 39 (14.9%) 117 (35.1%)  < 0.01*
  1. mean ± standard deviation or number (%). *means statistically significant; p values < 0.05
  2. IVIG Intravenous immunoglobulin, WBC White blood cells, ANC Absolute neutrophil counts, AST Aspartate aminotransferase, ALT Alanine transaminase, CRP C-reactive protein, NT-proBNP Nitrogen terminal-pro brain natriuretic peptide, CAD Coronary artery dilatation